FIELD: biotechnology and medicine.
SUBSTANCE: method for producing a hemostatic drug in the form of an aerogel based on bacterial cellulose and alginate, used to achieve a rapid hemostatic effect. Invention includes obtaining a biocomposite based on oxidized bacterial cellulose obtained by cultivating the producer Komagataeibacter sucrofermentans H-110 (VKPM-11267), calcium alginate, thrombin or factor X blood coagulation or thrombin and sodium fusidine, and obtaining an aerogel, the biocomposite is frozen in a low-temperature refrigerator for 1 day, after which it is freeze-dried.
EFFECT: hemostatic drug in the form of an aerogel based on oxidized bacterial cellulose and calcium alginate, which is able to stop bleeding within 60-120 seconds.
4 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING BIOCOMPOSITE BASED ON AIRGEL OF BACTERIAL CELLULOSE HAVING HAEMOSTATIC PROPERTIES | 2019 |
|
RU2736061C1 |
| METHOD OF PRODUCING BIOCOMPOSITE MATERIALS WITH REGENERATIVE AND ANTISEPTIC PROPERTIES BASED ON BACTERIAL CELLULOSE HYDROGELS | 2023 |
|
RU2814059C1 |
| METHOD FOR OBTAINING A BIOCOMPOSITE WITH ANTIBACTERIAL PROPERTIES BASED ON BACTERIAL CELLULOSE HYDROGEL | 2021 |
|
RU2771864C1 |
| METHOD OF PRODUCING BIOCOMPOSITE WITH REGENERATIVE PROPERTIES BASED ON HYDROGEL OF BACTERIAL CELLULOSE | 2019 |
|
RU2733137C1 |
| METHOD FOR PRODUCING CAPSULES BASED ON BACTERIAL CELLULOSE HYDROGELS | 2021 |
|
RU2775231C1 |
| METHOD OF PRODUCTION OF BIOCOMPOSITE | 2014 |
|
RU2564567C1 |
| HYDROGEL BIOCOMPOSITE BASED ON BACTERIAL POLYSACCHARIDES FOR USE IN TISSUE ENGINEERING | 2023 |
|
RU2819701C1 |
| METHOD FOR OBTAINING A WOUND HEALING GEL CONTAINING TRYPSIN FOR EXTERNAL USE | 2021 |
|
RU2778511C1 |
| METHOD FOR PRODUCTION OF HEMOSTATIC POROUS COMPOSITE MATERIAL | 2021 |
|
RU2789327C1 |
| METHOD OF PRODUCING AEROGEL BASED ON BACTERIAL CELLULOSE FOR SOUND-INSULATING MATERIAL | 2018 |
|
RU2700624C1 |
